Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases.
Is pleased to announce that a new corporate video is available to view on the Company’s website and can be accessed here
In addition, the Company also announces that Dr Vladislav Sandler, Chief Executive Officer & Co-Founder of Hemogenyx Pharmaceuticals will host a live investor webinar on 20 July 2020 at 16:00 UK time at which he will answer questions about the Company’s current activities.
If you would like to register for the webinar, please follow this link:
After registering, you will receive a confirmation email containing information about joining the meeting.
Please submit your questions in advance and not later than 17 July 2020 by emailing firstname.lastname@example.org .
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned